Hologic stock holds near $76 as takeover talk lingers
Published on 08/18/2026 at 10:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hologic (US4364401012) stock is trading near $76.00, with a $16.97 billion market value and a 52-week range of $51.90 to $76.07 as of August 17, 2026. The shares also sit on a Hold consensus rating, while the latest quarterly update showed $1.04 in earnings per share and revenue up 2.5% year over year.
Deal headlines keep the focus on valuation
Recent coverage has centered on Hologic's surgical business, with reports on July 9, 2026 and July 10, 2026 saying Blackstone and TPG were seeking more than $4 billion for the unit. That backdrop matters because the stock is already trading close to its 52-week high of $76.07, which leaves less room for disappointment.
For investors, the key point is that the current share price already reflects a lot of deal optimism and a decent operating base. The company reported $4.10 billion in annual sales, $565.70 million in net income and a 13.18 percent net margin in the most recent profile data.
What the numbers say
The current valuation snapshot puts Hologic at 31.67 times earnings and 3.35 times book value, while the forward P/E is 17.76. Those figures sit alongside analyst coverage of 12 firms and an average price target of $79.13, only a modest premium to the latest quote.
Hologic's most recent earnings line also shows a clear comparison point: $1.04 per share missed the $1.09 consensus by $0.05, even as revenue still grew 2.5 percent from the prior year. That mix of slower earnings momentum and steady sales growth helps explain why the market is treating the name as a valuation story rather than a pure growth trade.
Product angle
Hologic's portfolio still rests on women’s health and diagnostics, including mammography systems, molecular assays and cervical cancer screening tools. One visible recent product note was the July 14, 2026 expansion of CE-IVDR marking for the Aptima HPV Test to include self-collected sample claims in cervical cancer screening.
Closing levels matter
At $76.00, the stock is sitting just below its $76.07 52-week high and well above the $51.90 low. That makes the next move more dependent on deal clarity, margin delivery and the next earnings update than on broad market sentiment alone.
Facts at a glance
Company: Hologic, Inc.
ISIN: US4364401012
Ticker: HOLX
Exchange: NASDAQ
Price (as of August 17, 2026): $76.00 USD
Market cap: $16.97 billion
Sector / Industry: Healthcare / Healthcare Equipment
Index membership: Nasdaq-100
